SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing heightened investor attention as the market rotates into quantum computing stocks, buoyed by significant industry partnerships with NVIDIA and active government contracts for space and defense applications. The community is actively discussing the stock's potential for a valuation re-rating, highlighting its neutral-atom technology and institutional interest as key drivers for long-term growth versus shorter-term momentum peers.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors rally around the company's confirmed control of 92.5% of the Tanbreez rare earth project following final regulatory approval from Greenland. The community is focused on the stock's potential as a strategic play for Western supply chain independence and is actively debating whether current momentum will lead to a sustained breakout or a near-term consolidation.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending following a post-earnings sell-off where investors reacted negatively to weak forward guidance and the departure of co-founder Reed Hastings from the board, despite the company posting strong quarterly revenue and profit figures. While many retail participants are framing the price drop as a "no-brainer" buying opportunity and actively loading up on dips, others are debating whether the stock is undergoing a structural narrative shift or simply experiencing a temporary liquidity reset after a strong pre-earnings run.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and significant debate as investors react to the company's aggressive Bitcoin acquisition strategy and its correlation with crypto market movements. Community sentiment is deeply divided between bulls betting on a massive short squeeze driven by institutional accumulation, and skeptics who are raising concerns over the sustainability of its debt-funded business model.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is currently trending as investors focus on the potential of its CAN-2409 immunotherapy platform and upcoming data presentations for prostate and lung cancer. The community is actively discussing the company's regulatory progress, recent insider accumulation, and the potential for a significant valuation re-rating ahead of expected BLA filings.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. (ASST) is trending as investors react to aggressive institutional accumulation and the companys ongoing strategy of utilizing digital credit to increase its Bitcoin treasury holdings. Community sentiment remains polarized, with bulls focused on the potential for long-term growth as a Bitcoin proxy, while critics remain vocal about the stock's history of dilution and the impact of previous reverse splits.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing high volatility driven by reports of an anticipated executive order from the White House supporting research into ibogaine for PTSD treatment. While some community members are betting on a massive short squeeze due to the stock's low float and high speculative interest, others are warning of dilution risks and past patterns of aggressive selling, leading to intense debate among traders regarding the sustainability of the current price action.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is experiencing significant volatility and downward pressure as market sentiment reacts to competitive threats from new AI-powered design tools, despite some community members remaining bullish on its long-term enterprise dominance and integration capabilities. Investors are actively debating whether current price levels represent a generational buying opportunity or a structural decline as the company navigates an increasingly crowded software ecosystem.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is sparking intense debate as community members weigh the potential of the newly launched LitVM testnet against ongoing price stagnation and concerns over lagging performance compared to broader crypto markets. While some investors remain bullish on its foundational reliability, institutional accumulation, and future utility, others dismiss recent updates as ineffective, leading to a polarized discussion around long-term viability and the asset's ability to decouple from recent downward trends.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is currently capturing significant attention as investors speculate on a broader nuclear sector rally, fueled by a positive mandate from the White House regarding space-based nuclear energy and an ongoing institutional board reorganization. The community remains deeply divided, balancing excitement over potential long-term commercial milestones like Aurora reactor criticality against skepticism regarding the company's lack of current revenue and the heavy volume of insider share sales.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TMO Q1 Earnings Preview: Will Life Sciences Solutions Lead Results?

Thermo Fisher heads into Q1 earnings with Life Sciences Solutions growth in focus, as bioproduction strength and new innovations may drive results.

Short Interest in OnKure Therapeutics, Inc. (NASDAQ:OKUR) Increases By 1,958.6%

OnKure Therapeutics, Inc. (NASDAQ:OKUR - Get Free Report) saw a large increase in short interest in March. As of March 31st, there was short interest totaling 163,904 shares, an increase of 1,958.6% from the March 15th total of 7,962 shares. Based on an average daily volume of 786,389 shares, the...

OnKure Therapeutics, Inc. (NASDAQ:OKUR) Short Interest Down 85.2% in March

OnKure Therapeutics, Inc. (NASDAQ:OKUR - Get Free Report) was the target of a significant decline in short interest in March. As of March 13th, there was short interest totaling 7,962 shares, a...

HC Wainwright Has Positive Forecast for OKUR Q1 Earnings

OnKure Therapeutics, Inc. (NASDAQ:OKUR - Free Report) - Stock analysts at HC Wainwright upped their Q1 2026 earnings per share (EPS) estimates for OnKure Therapeutics in a research note issued to...

OnKure Therapeutics (NASDAQ:OKUR) Price Target Lowered to $27.00 at HC Wainwright

HC Wainwright dropped their price objective on OnKure Therapeutics from $34.00 to $27.00 and set a "buy" rating on the stock in a research report on Monday...

OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer. It is headquartered in Boulder, CO.

OKUR
Onkure Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest OKUR News

OKUROnkure Therapeutics Inc